IJBST 2018 Volume 11 Issue 7

International Journal of BioSciences and Technology (IJBST) ISSN: 0974-3987

IJBST Journal Group -- Open Access -- NO Fees -- NO Processing Charges -- 100% Non Profit Initiatives

The IJBST Journal Group subscribes to the San Francisco Declaration on Research Assessment and the The European Code of Conduct for Research Integrity

The IJBST Journal Group Archive can also be accessed at https://archive.org/details/IJBSTJournalGroup

Imesha Rashmini Rathnayaka, & Nivethika Sivakumaran. (2018). Stem Cell Immunotherapy for HIV Patients and Drawbacks. International Journal of Biosciences and Technology (IJBST) ISSN: 0974-3987, 11(7), 60–65. http://doi.org/10.5281/zenodo.1493684


Stem Cell Immunotherapy for HIV Patients and Drawbacks

Authors & Affiliation:

Imesha Rashmini Rathnayaka1, Nivethika Sivakumaran2

1 & 2 Department of Biomedical Science, International College of Business and Technology, No 36, De Kretser Place, Bambalapitiya, Colombo 04, SRI LANKA

2 School of Science, Edulink International Campus, No 6, Glen Aber Place, Bambalapitiya, Colombo 04, SRI LANKA

snivethika25@gmail.com, imasharashmini@gmail.com


Stem cell transplantation immunotherapy for HIV emerges since the 1980s. This therapy is can be used to reestablish the immune system of HIV patients. The ultimate goal of stem cell transplantation is clearing the virus from the patient's body. Dominating strategies in this field are combination of gene editing mechanisms with stem cell therapy to develop cytotoxic anti-HIV cells, modify stem cells using artificial and natural stem cell sources etc. Stem cell transplantation with modified zinc finger nuclease might be a promising cure for HIV infection in the future.

Key words: Cytotoxic, HIV, Immunotherapy, Lentivirus